Skip to main content

AGIO

Agios Pharmaceuticals, Inc.

Company with tickers: AGIO

CIK
1439222
CUSIP
00847X104
Shares Outstanding
59,471,609
13F Activity (30d)
156 filings 139 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 235
Total Value: $2,269,384,337
Total Shares: 67,082,013
Showing 1–100 of 248 holdings by value · page 1 of 3

Institutional Ownership Trend

28 quarters

Holder Concentration

Across 235 13F filers · Δ vs Dec 31, 2025
Top Holder
8.8%
Mar 2024 → Mar 2026 · range 8.8% – 12.9%
−3.7 pts
Top 5
34.9%
Mar 2024 → Mar 2026 · range 34.9% – 50.1%
−6.5 pts
Top 10
53.0%
Mar 2024 → Mar 2026 · range 52.6% – 66.6%
−4.9 pts
HHI
385
Mar 2024 → Mar 2026 · range 385 – 631
Broadly held−99

Quarterly Activity

vs Dec 31, 2025
New
58
Increased
75
Decreased
70
Sold Out
38
Unchanged
32
Holder count: +20
Institutional value: +72.6%
Shares held: +38.9%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 100 of 248
Export CSV
Holder Value (USD) % of 13F Shares Open